Your session is about to expire
← Back to Search
CORT125281 for Prostate Cancer
Study Summary
This trial is testing a new cancer drug to see if it is safe and effective.
- Metastatic Castration Resistant Prostate Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any previous investigations featuring CORT125281?
"In 2005, the first CORT125281 trial was conducted at Rosemere Cancer Centre in Royal Preston Hospital. Since then, 18402 trials have been completed and 98 are still undergoing clinical testing; many of which occur within Madison, Wisconsin's medical community."
Is this clinical investigation taking place in multiple Canadian healthcare facilities?
"The investigation is currently enrolling patients from 5 different locations, including Madison, Scottsdale and Detroit. It might be beneficial to select the most proximal site in order to reduce travel demands if you decide to partake."
What is the estimated recruitment for this trial?
"Affirmative. According to clinicaltrials.gov, this investigation is actively recruiting participants as of November 1st 2021. It was first listed on December 15th 2017 and requires 80 volunteers from 5 different sites."
Are any positions still available for participants in this experiment?
"Affirmative. Clinicaltrials.gov reveals that this trial is actively recruiting patients, with an initial post date of December 15th 2017 and a recent update on November 1st 2021. 80 individuals need to be enrolled from 5 different medical facilities."
Share this study with friends
Copy Link
Messenger